Method of treating binge eating disorder

Abstract

The invention provides methods of treating binge eating disorders, obesity resulting from binge eating behavior, and depression. The invention includes methods of treating certain co-morbidities in ADHD and ADD patients; for example the invention includes methods of treating generalized anxiety disorder, obsessional and ruminative thought disorders, and obsessive/compulsive behavior in ADHD and ADD patients. The invention also includes combination methods of treatment in which an amphetamine prodrug, methylphenidate prodrug, or methylphenidate analog is administered with one or more other active agents. Packaged pharmaceutical compositions containing an amphetamine or methylphenidate prodrug, instructions for using the prodrug to treat certain disorders, and optionally one or more other active agents are provided by the invention.

1 - 15 . (canceled) 
     
     
         16 . A method of using lisdexamfetamine dimesylate comprising informing a user that the lisdexamfetamine dimesylate may be used to treat Binge Eating Disorder as defined in the DSM-IV-TR. 
     
     
         17 - 18 . (canceled) 
     
     
         19 . The method of  claim 16 , additionally comprising providing lisdexamfetamine dimesylate in a container and the informing is by reference to a package insert associated with the container. 
     
     
         20 . The method of  claim 16 , wherein the informing is by reference to information material; by reference to a package active agent insert, a flyer or an advertisement; by presentation of information at a seminar, conference, or other educational presentation; or by a conversation between a pharmaceutical sales representative and a medical care worker. 
     
     
         21 - 25 . (canceled) 
     
     
         26 . A method of using lisdexamfetamine dimesylate comprising (i) conducting a clinical trial of the efficacy of the lisdexamfetamine dimesylate for treating Binge Eating Disorder as defined in DSM-IV-TR and (ii) informing a purchaser of the lisdexamfetamine dimesylate that the lisdexamfetamine dimesylate is efficacious for treating Binge Eating Disorder. 
     
     
         27 - 28 . (canceled) 
     
     
         29 . The method of  claim 26 , wherein the clinical trial generates data that is submitted to the FDA.